Gene therapy

In T1D, islets are the target for autoreactive T cell destruction. The absence of islets leads to insulin deficiencies and resultant hyperglycemia. Gene therapy is a useful technique to treat T1D as it can be applied from many different angles. The insulin gene can be replaced in a host or the autoreactive T cells suppressed.

    Related Conference of Gene therapy

    September 28-29, 2018

    2nd International Conference on Diabetes and Diabetic Nursing Care

    Montreal, Quebec, Canada
    November 21-22, 2018

    14th World Congress on Endocrinology & Diabetes

    Paris, France
    November 26-27, 2018

    26th International Diabetes and Healthcare Conference

    Helsinki, Finland
    November 26-27, 2018

    13th European Diabetes and Endocrinology Congress

    Dublin, Ireland

    March 28-29, 2019

    21st Asia Pacific Diabetes Conference

    Osaka,Japan
    May 16-17, 2019

    2nd Global Meeting on Diabetes and Endocrinology

    Abu Dhabi, UAE

    28th European Diabetes Congress

    June 10-11, 2019 | Edinburgh, Scotland
    July 24-25, 2019

    29th World Diabetes & Heart Congress

    Melbourne, Australia
    Oct 03-04, 2019

    Euro Diabetes Congress & Expo

    | Paris, France

    Gene therapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in